These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21220981)

  • 1. F-18 FDG avid primary CNS lymphoma located in the ventricles.
    Can N; Ulubay H; Yakupoğlu H; Celasun B; Unlü M
    Clin Nucl Med; 2011 Feb; 36(2):138-40. PubMed ID: 21220981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse FDG renal uptake in lymphoma.
    Navalkissoor S; Szyszko T; Gnanasegaran G; Nunan T
    Clin Nucl Med; 2010 Oct; 35(10):813-5. PubMed ID: 20838296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 FDG PET/CT in primary tonsillar lymphoma.
    Zhang MJ; Jiang JJ; Jiang MS; He W
    Clin Nucl Med; 2010 Sep; 35(9):710-2. PubMed ID: 20706049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-18 FDG PET/CT imaging of intraventricular germinoma.
    Yu CH; Peller PJ; Subramaniam R
    Clin Nucl Med; 2009 Jun; 34(6):393-4. PubMed ID: 19487857
    [No Abstract]   [Full Text] [Related]  

  • 6. A Rare Case of Primary Ventricular Lymphoma Presented on FDG PET/CT.
    Wang D; Su M; Xiao J
    Clin Nucl Med; 2020 Feb; 45(2):156-158. PubMed ID: 31833937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
    Lin EC
    Clin Nucl Med; 2007 Feb; 32(2):152-3. PubMed ID: 17242576
    [No Abstract]   [Full Text] [Related]  

  • 8. 18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.
    Ye XH; Chen LH; Wu HB; Feng J; Zhou WL; Yang RM; Bu ZB; Ding Y; Guan J; Wang QS
    South Med J; 2010 Jul; 103(7):642-9. PubMed ID: 20531045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.
    Weiler-Sagie M; Bushelev O; Epelbaum R; Dann EJ; Haim N; Avivi I; Ben-Barak A; Ben-Arie Y; Bar-Shalom R; Israel O
    J Nucl Med; 2010 Jan; 51(1):25-30. PubMed ID: 20009002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased brain FDG uptake in patients with extensive non-Hodgkin's lymphoma lesions.
    Hanaoka K; Hosono M; Shimono T; Usami K; Komeya Y; Tsuchiya N; Yamazoe Y; Ishii K; Tatsumi Y; Sumita M
    Ann Nucl Med; 2010 Dec; 24(10):707-11. PubMed ID: 20824395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of brain FDG-PET in primary CNS lymphoma.
    Mohile NA; Deangelis LM; Abrey LE
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):818-20, 840. PubMed ID: 19194366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
    Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.
    Ito K; Shida Y; Kubota K; Morooka M; Aruga T; Itami J; Matsuda H
    Ann Nucl Med; 2010 Nov; 24(9):649-54. PubMed ID: 20740330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.
    Allen-Auerbach M; de Vos S; Czernin J
    Radiol Clin North Am; 2008 Mar; 46(2):199-211, vii. PubMed ID: 18619376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
    Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
    Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: case series and literature review.
    Bronstein Y; Tummala S; Rohren E
    Clin Nucl Med; 2011 Feb; 36(2):96-100. PubMed ID: 21220969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
    van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
    J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG Uptake in a T2 Hypointense Paraspinal Mass.
    Singhal A; Adhikari N; de Idiaquez Bakula DA; Sotoudeh H
    Clin Nucl Med; 2020 May; 45(5):385-386. PubMed ID: 32149807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.